European leader in the production and commercialisation of PET (Positron Emission Tomography) and SPECT (Single Photon Emission Tomography) radiopharmaceuticals and is able to produce and deliver both commercial drugs and research products.
For 30 years, we have worked for leading edge companies and organizations involved in a wide range of emerging technologies
Specialized in the discovery of new Biomarkers and the development of innovative Diagnostics focused on personalized medicine applications.
Development and marketing of advanced biological diagnostic tools for the medical professions with focus on autoimmune diseases, allergies, infectious diseases and immunochemical tests for coronary problems.
First manufacturer to develop a full line of tools for microbiology laboratories, from sample collection to results, using technologies including flow and laser scanning cytometry, molecular biology, culture media or metrology.
e-ophtalmo, société de e-santé, a mis au point une solution complète et sécurisée de télémédecine spécialisée en ophtalmologie.
Development and manufacture of medical devices for the early diagnosis of neurological diseases.
Development and marketing of novel diagnostic tests for cancer and genetic diseases.
Development and marketing of advanced in vitro diagnostic kits for clinical use. Primary focus is on infectious diseases and immunology, including HLA testing.
Development and marketing of magnetic bioassays to improve rapid diagnostic performance for human and animal diagnostics, food safety and environmental protection testing.
Rapid, accurate and low-cost diagnosis and monitoring of metabolic and infectious diseases through the simple and non-invasive analysis of breath.
Spun out of the Pasteur Institute and l’ENVA, a new generation molecular diagnostics company that offers a game changing approach in the diagnosis of infectious diseases.
Development, manufacture and marketing of protein electrophoresis tests and analysers, dedicated to the in vitro diagnosis of cancer, inflammatory, metabolism and haemoglobin disorders.
Genomic disease management. Development and marketing of clinical products providing information critical to the evaluation and management of cancer, prenatal disorders and other genetic diseases.